Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory System Agents”

364 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 364 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more
Exelixis 1,314
Not applicableStudy completedNCT00005572
What this trial is testing

A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus RetinitisPneumonia, Pneumocystis Carinii+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT03349567
What this trial is testing

Improving Antimicrobial-Prescribing in Emergency Departments

Who this might be right for
Anti-Bacterial AgentsRespiratory Tract Infections
Iowa City Veterans Affairs Medical Center 27
Large-scale testing (Phase 3)Study completedNCT04590586
What this trial is testing

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Who this might be right for
COVID-19
Amgen 515
Not applicableActive Not RecruitingNCT06144242
What this trial is testing

Improving Antibiotic Use for ARIs in Urgent Care Clinics

Who this might be right for
Antibacterial AgentsAmbulatory Care
Daniel Livorsi 90
Post-approval studies (Phase 4)Study completedNCT04089787
What this trial is testing

Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia

Who this might be right for
Community-acquired Pneumonia
Thomas Benfield 395
Post-approval studies (Phase 4)WithdrawnNCT03167281
What this trial is testing

Early Intrapleural TPA Instillation Versus Late

Who this might be right for
Tissue Plasminogen Activator
Prisma Health-Midlands
Not applicableStudy completedNCT02468102
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Who this might be right for
Acute Coronary SyndromeVenous ThrombosisPulmonary Embolism+1 more
Bayer 99,999
Post-approval studies (Phase 4)WithdrawnNCT04330495
What this trial is testing

Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection

Who this might be right for
COVID 19Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
Instituto de Investigación Marqués de Valdecilla
Testing effectiveness (Phase 2)Study completedNCT03822351
What this trial is testing

Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC

Who this might be right for
Stage III Non-small Cell Lung CancerUnresectable
MedImmune LLC 189
Large-scale testing (Phase 3)Study completedNCT00249210
What this trial is testing

The Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses

Who this might be right for
SinusitisMaxillary Sinusitis
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 614
Early research (Phase 1)UnknownNCT05525650
What this trial is testing

Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients

Who this might be right for
Mite AllergyRhinitis, AllergicHouse Dust Mite Rhinitis
RAPHAS 54
Not applicableLooking for participantsNCT07637474
What this trial is testing

Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients

Who this might be right for
Nsclc
Regina Elena Cancer Institute 150
Large-scale testing (Phase 3)Study completedNCT00319306
What this trial is testing

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

Who this might be right for
Asthma
AstraZeneca 550
Testing effectiveness (Phase 2)Looking for participantsNCT07227298
What this trial is testing

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung CancerCarcinoma, Non-Small Cell LungNon-Small Cell Lung Cancer
Pfizer 162
Not applicableUnknownNCT05183841
What this trial is testing

Bronchodilators on the Exercise Capacity of Bronchiectasis Patients

Who this might be right for
Bronchiectasis Adult
University of Sao Paulo General Hospital 40
Large-scale testing (Phase 3)Study completedNCT00000802
What this trial is testing

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 700
Early research (Phase 1)Study completedNCT06494345
What this trial is testing

Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers

Who this might be right for
Allergic Asthma
AO GENERIUM 180
Not applicableStudy completedNCT04453501
What this trial is testing

Anti Infective Agents Impact in COVID-19 Pneumonia

Who this might be right for
COVIDPneumonia, Viral
Centre d'Investigation Clinique et Technologique 805 132
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Load More Results